Aptose Biosciences Inc. (TSX:APS)
Canada flag Canada · Delayed Price · Currency is CAD
1.750
+0.170 (10.76%)
Aug 25, 2025, 3:24 PM EDT

Aptose Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Selling, General & Admin
11.6311.1515.5914.5119.4626.48
Upgrade
Research & Development
9.9115.136.7728.0945.9929.29
Upgrade
Operating Expenses
21.5326.2652.3642.665.4555.77
Upgrade
Operating Income
-21.53-26.26-52.36-42.6-65.45-55.77
Upgrade
Interest Expense
-0.4-0.21----
Upgrade
Interest & Investment Income
0.140.361.150.790.090.52
Upgrade
Currency Exchange Gain (Loss)
-0.02-0.01-0-0.01-00.01
Upgrade
Other Non Operating Income (Expenses)
0.690.69----
Upgrade
Pretax Income
-21.12-25.43-51.21-41.82-65.35-55.24
Upgrade
Net Income
-21.12-25.43-51.21-41.82-65.35-55.24
Upgrade
Net Income to Common
-21.12-25.43-51.21-41.82-65.35-55.24
Upgrade
Shares Outstanding (Basic)
210000
Upgrade
Shares Outstanding (Diluted)
210000
Upgrade
Shares Change (YoY)
337.23%210.44%9.81%3.57%8.86%63.15%
Upgrade
EPS (Basic)
-13.04-36.38-227.43-203.98-330.12-303.74
Upgrade
EPS (Diluted)
-13.04-36.38-227.43-203.98-330.12-303.74
Upgrade
Free Cash Flow
-27.18-35.98-44.62-32.35-43.52-33.97
Upgrade
Free Cash Flow Per Share
-16.77-51.48-198.17-157.76-219.81-186.79
Upgrade
EBITDA
-21.52-26.23-52.27-42.48-65.3-55.62
Upgrade
D&A For EBITDA
0.020.030.090.120.150.15
Upgrade
EBIT
-21.53-26.26-52.36-42.6-65.45-55.77
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.